Boot H - Search Results

1

Combined diagnostic imaging with 131I-metaiodobenzylguanidine and 111In-pentetreotide in carcinoid tumours.

Taal BG, Hoefnagel CA, Valdés Olmos RA, Boot H. Taal BG, et al. Among authors: boot h. Eur J Cancer. 1996 Oct;32A(11):1924-32. doi: 10.1016/0959-8049(96)00241-9. Eur J Cancer. 1996. PMID: 8943676 Clinical Trial.

2

Palliative effect of metaiodobenzylguanidine in metastatic carcinoid tumors.

Taal BG, Hoefnagel CA, Valdes Olmos RA, Boot H, Beijnen JH. Taal BG, et al. Among authors: boot h. J Clin Oncol. 1996 Jun;14(6):1829-38. doi: 10.1200/JCO.1996.14.6.1829. J Clin Oncol. 1996. PMID: 8656251

3

Modulation of toxicity following external beam irradiation preceded by high-dose rate brachytherapy in inoperable oesophageal cancer.

Taal BG, Aleman BM, Koning CC, Boot H. Taal BG, et al. Among authors: boot h. Eur J Cancer. 1996 Sep;32A(10):1815-8. doi: 10.1016/0959-8049(96)00156-6. Eur J Cancer. 1996. PMID: 8983296 Clinical Trial.

4

Long-term palliation in metastatic carcinoid tumours with various applications of meta-iodobenzylguanidin (MIBG): pharmacological MIBG, 131I-labelled MIBG and the combination.

Zuetenhorst H, Taal BG, Boot H, Valdes Olmos R, Hoefnagel C. Zuetenhorst H, et al. Among authors: boot h. Eur J Gastroenterol Hepatol. 1999 Oct;11(10):1157-64. doi: 10.1097/00042737-199910000-00014. Eur J Gastroenterol Hepatol. 1999. PMID: 10524647

5

Enhancement of 131I-MIBG uptake in carcinoid tumours by administration of unlabelled MIBG.

Hoefnagel CA, Taal BG, Sivro F, Boot H, Valdes Olmos RA. Hoefnagel CA, et al. Among authors: boot h. Nucl Med Commun. 2000 Aug;21(8):755-61. doi: 10.1097/00006231-200008000-00009. Nucl Med Commun. 2000. PMID: 11039459 Clinical Trial.

6

Improved effect of 131I-MIBG treatment by predosing with non-radiolabeled MIBG in carcinoid patients, and studies in xenografted mice.

Taal BG, Hoefnagel C, Boot H, Valdés Olmos R, Rutgers M. Taal BG, et al. Among authors: boot h. Ann Oncol. 2000 Nov;11(11):1437-43. doi: 10.1023/a:1026592025862. Ann Oncol. 2000. PMID: 11142484 Free article.

7

Evaluation of (111)In-pentetreotide, (131)I-MIBG and bone scintigraphy in the detection and clinical management of bone metastases in carcinoid disease.

Zuetenhorst JM, Hoefnageli CA, Boot H, Valdés Olmos RA, Taal BG. Zuetenhorst JM, et al. Among authors: boot h. Nucl Med Commun. 2002 Aug;23(8):735-41. doi: 10.1097/00006231-200208000-00006. Nucl Med Commun. 2002. PMID: 12124478 Clinical Trial.

8

Assessment of sucralfate coating by sequential scintigraphic imaging in radiation-induced esophageal lesions.

Taal BG, Vales Olmos RA, Boot H, Hoefnagel CA. Taal BG, et al. Among authors: boot h. Gastrointest Endosc. 1995 Feb;41(2):109-14. doi: 10.1016/s0016-5107(05)80591-7. Gastrointest Endosc. 1995. PMID: 7720996

9

High dose rate brachytherapy before external beam irradiation in inoperable oesophageal cancer.

Taal BG, Aleman BM, Koning CC, Boot H. Taal BG, et al. Among authors: boot h. Br J Cancer. 1996 Nov;74(9):1452-7. doi: 10.1038/bjc.1996.564. Br J Cancer. 1996. PMID: 8912544 Free PMC article. Clinical Trial.

10

[Carcinoid tumors of the intestines: developments in the Netherlands for diagnosis and palliative treatment].

Taal BG, Hoefnagel C, Boot H, de Jong D, Rutgers M. Taal BG, et al. Among authors: boot h. Ned Tijdschr Geneeskd. 1999 Feb 27;143(9):445-51. Ned Tijdschr Geneeskd. 1999. PMID: 10221120 Review. Dutch.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

235 results

Search Page

Filters